ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...
Gentel® Biosciences has announced that it has obtained an exclusive license to novel technology for manufacturing highly-reproducible nitrocellulose protein microarray slides. The technology, ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...
Recently published data generated by researchers at The University of Queensland and Vaxxas shows effective delivery of a nucleic acid-based COVID-19 vaccine in a preclinical animal study utilizing ...
The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...
Australian biotech Vaxxas strengthens its board with vaccine executive Brent MacGregor as it advances its needle-free HD-MAP ...
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch” technology and utilizes Micron's first-in-class dissolvable microarray technology Research builds on Emory's ...
"[People] had been developing Arabidopsis microarrays for a number of years, and these were some of the first papers that published high-quality data with real biological conclusions," says Chris Town ...
HAYWARD, CA--(Marketwired - March 24, 2016) - Biolog, Inc. announced today that it has received another patent on its Phenotype MicroArray™ (PM) technology, extending the breadth and depth of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback